Clinical Updates
Drug approvals, guideline changes, and treatment advances
Blood test with circular RNA markers predicts Alzheimer’s disease years before symptoms emerge
A blood test measuring 34 circular RNA markers predicts Alzheimer's disease progression with 92% accuracy, outperforming current protein biomarkers and…
Editor's Top Picks
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Submit Your Paper →
More form Clinical Updates
How neurotransmitters orchestrate mood, sleep, and cognition: a biochemical primer
Brain function depends on chemical communication between neurons through neurotransmitters. Twelve major neurotransmitter systems regulate…
Vitamin D’s Role in Alzheimer’s Tau Accumulation: New Evidence from Framingham Heart Study
A 16-year analysis from the Framingham Heart Study finds that higher vitamin D levels in…
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained
Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations (PTEN loss, TP53,…
EMA Launches Email Notifications for Clinical Trial Information System
The European Medicines Agency has rolled out email notification subscriptions in CTIS, enabling clinical trial…
Australia Reports First High Pathogenicity H5N1 Case in Wild Bird
Australia has confirmed its first detection of High Pathogenicity Avian Influenza H5N1 in a wild…